Hearing Loss Disease Portal


 
Switch to table view
Most Common: Hearing Loss (D034381), Deafness (D003638), Sensorineural HL (D006319), Waardenburg Syndrome, Usher Syndromes
Disease Browser
Parent Node:
expand
Diseases (C)
Parent Node:
expand
Megacystis microcolon intestinal hypoperistalsis syndrome (C536138)
Parent Node:
expand
Visceral Myopathy, Familial (C562574)
..Starting node
..expand
VISCERAL MYOPATHY (OMIM:155310)

       Child Nodes:



 Sister Nodes: 
..expandVISCERAL MYOPATHY (OMIM:155310)
   

Human Disease MESH is developed by UMLS.
Further data from MedGen, OMIM, CTD
Term ID:11612
Name:VISCERAL MYOPATHY
Definition:
Alternative IDs:
ParentIDs:MESH:C536138|MESH:C562574
TreeNumbers:C06.405.469.531.492.500/C536138/155310 |C06.405.469.531.492.500/C562574/155310 |C16.131.077/C536138/155310
Synonyms:BERDON SYNDROME |INFANTILE VISCERAL MYOPATHY |MEGACYSTIS-MICROCOLON-INTESTINAL HYPOPERISTALSIS SYNDROME |MEGADUODENUM AND/OR MEGACYSTIS |MMIH |PSEUDOOBSTRUCTION, IDIOPATHIC INTESTINAL |VSCM
Slim Mappings:Congenital abnormality|Digestive system disease
Reference: MedGen: 155310
MeSH: 155310
OMIM: 155310;

Genes: ACTG2;
Phenotypes
1 HP:0000006Autosomal dominant inheritance
2 HP:0002251Aganglionic megacolon
3 HP:0002019Constipation
4 HP:0002014Diarrhea
5 HP:0002015Dysphagia
6 HP:0000126Hydronephrosis
7 HP:0004389Intestinal pseudo-obstruction
8 HP:0004395Malnutrition
9 HP:0000021Megacystis
10 HP:0004388Microcolon
11 HP:0001733PancreatitisHP:0040283
12 HP:0001561Polyhydramnios
13 HP:0000076Vesicoureteral reflux
14 HP:0002013Vomiting
Disease Causing ClinVar Variants
Variation_NameGeneIDGeneSymbolClinicalSignificancedbSNPRCVaccessionTestedInGTRPhenotypeIDsChromosomeStartStopHGVS_cHGVS_pHGVS_gOtherIDsDisease_ClinVarDisease_hgmd
NM_001615.3(ACTG2):c.118C>T (p.Arg40Cys)72ACTG2Pathogenic587777385RCV000119268; NMedGen:C1835084,OMIM:155310, Orphanet:ORPHA224127412855674128556NM_001615.3:c.118C>TNP_001606.1:p.Arg40Cys2:g.74128556C>TOMIM Allelic Variant:102545.0006C1835084 155310 Visceral myopathy
NM_001615.3(ACTG2):c.119G>A (p.Arg40His)72ACTG2Pathogenic587777386RCV000119271; NMedGen:C1835084,OMIM:155310, Orphanet:ORPHA224127412855774128557NM_001615.3:c.119G>ANP_001606.1:p.Arg40His2:g.74128557G>AOMIM Allelic Variant:102545.0005C1835084 155310 Visceral myopathy
NM_001615.3(ACTG2):c.134T>C (p.Met45Thr)72ACTG2Pathogenic864309490RCV000202556; NMedGen:C1835084,OMIM:155310, Orphanet:ORPHA224127412949474129494NM_001615.3:c.134T>CNP_001606.1:p.Met45ThrNC_000002.11:g.74129494T>C-C1835084 155310 Visceral myopathy
NM_001615.3(ACTG2):c.187C>G (p.Arg63Gly)72ACTG2Pathogenic864309491RCV000202512; NMedGen:C1835084,OMIM:155310, Orphanet:ORPHA224127412954774129547NM_001615.3:c.187C>GNP_001606.1:p.Arg63GlyNC_000002.11:g.74129547C>G-C1835084 155310 Visceral myopathy
NM_001615.3(ACTG2):c.255+210C>A72ACTG2Pathogenic768290597RCV000202559; NMedGen:C1835084,OMIM:155310, Orphanet:ORPHA224127412982574129825NM_001615.3:c.255+210C>ANC_000002.11:g.74129825C>A-C1835084 155310 Visceral myopathy
NM_001615.3(ACTG2):c.400T>A (p.Tyr134Asn)72ACTG2Pathogenic587777388RCV000119274; NMedGen:C1835084,OMIM:155310, Orphanet:ORPHA224127413621574136215NM_001615.3:c.400T>ANP_001606.1:p.Tyr134Asn2:g.74136215T>AOMIM Allelic Variant:102545.0009C1835084 155310 Visceral myopathy
NM_001615.3(ACTG2):c.442C>A (p.Arg148Ser)72ACTG2Pathogenic587777383RCV000119266; RCV000210361; NMedGen:C0238062, Orphanet:ORPHA2978; MedGen:C1835084,OMIM:155310, Orphanet:ORPHA224127413625774136257NM_001615.3:c.442C>ANP_001606.1:p.Arg148Ser2:g.74136257C>AOMIM Allelic Variant:102545.0001C0238062 Chronic intestinal pseudoobstruction; C1835084 155310 Visceral myopathy
NM_001615.3(ACTG2):c.443G>T (p.Arg148Leu)72ACTG2Likely pathogenic730880256RCV000157596; NMedGen:C1835084,OMIM:155310, Orphanet:ORPHA224127413625874136258NM_001615.3:c.443G>TNP_001606.1:p.Arg148LeuNC_000002.11:g.74136258G>T-C1835084 155310 Visceral myopathy
NM_001615.3(ACTG2):c.532C>T (p.Arg178Cys)72ACTG2Pathogenic78001248RCV000119269; NMedGen:C1835084,OMIM:155310, Orphanet:ORPHA224127414069274140692NM_001615.3:c.532C>TNP_001606.1:p.Arg178CysNC_000002.11:g.74140692C>TOMIM Allelic Variant:102545.0003C1835084 155310 Visceral myopathy
NM_001615.3(ACTG2):c.533G>T (p.Arg178Leu)72ACTG2Pathogenic587777384RCV000119267; NMedGen:C1835084,OMIM:155310, Orphanet:ORPHA224127414069374140693NM_001615.3:c.533G>TNP_001606.1:p.Arg178Leu2:g.74140693G>TOMIM Allelic Variant:102545.0002C1835084 155310 Visceral myopathy
NM_001615.3(ACTG2):c.533G>A (p.Arg178His)72ACTG2Pathogenic587777384RCV000119270; RCV000190653; NMedGen:C0950123; MedGen:C1835084,OMIM:155310, Orphanet:ORPHA224127414069374140693NM_001615.3:c.533G>ANP_001606.1:p.Arg178His2:g.74140693G>AOMIM Allelic Variant:102545.0004C0950123 Inborn genetic diseases; C1835084 155310 Visceral myopathy
NM_001615.3(ACTG2):c.593G>A (p.Gly198Asp)72ACTG2Pathogenic864309492RCV000202479; NMedGen:C1835084,OMIM:155310, Orphanet:ORPHA224127414075374140753NM_001615.3:c.593G>ANP_001606.1:p.Gly198AspNC_000002.11:g.74140753G>A-C1835084 155310 Visceral myopathy
NM_001615.3(ACTG2):c.769C>T (p.Arg257Cys)72ACTG2Pathogenic587777387RCV000119272; RCV000210354; RCV000190747; NHuman Phenotype Ontology:HP:0000021,Human Phenotype Ontology:HP:0002838,MedGen:C1855311; MedGen:C0238062, Orphanet:ORPHA2978; MedGen:C0950123; MedGen:C1835084,OMIM:155310, Orphanet:ORPHA224127414196274141962NM_001615.3:c.769C>TNP_001606.1:p.Arg257Cys2:g.74141962C>TOMIM Allelic Variant:102545.0007C0238062 Chronic intestinal pseudoobstruction; C0950123 Inborn genetic diseases; C1855311 Megacystis; C1835084 155310 Visceral myopathy
NM_001615.3(ACTG2):c.806_807delGCinsAA (p.Gly269Glu)72ACTG2Pathogenic587777870RCV000144704; NMedGen:C1835084,OMIM:155310, Orphanet:ORPHA224127414371174143712NM_001615.3:c.806_807delGCinsAANP_001606.1:p.Gly269GluNC_000002.11:g.74143711_74143712delGCinsAA-C1835084 155310 Visceral myopathy
NM_022844.2(MYH11):c.3598A>T (p.Lys1200Ter)4629MYH11Likely pathogenic786205435RCV000172830; NMedGen:C1835084,OMIM:155310, Orphanet:ORPHA2241161582647415826474NM_022844.2:c.3598A>TNP_074035.1:p.Lys1200TerNC_000016.9:g.15826474T>A-C1835084 155310 Visceral myopathy